Onconova Therapeutics (NASDAQ: ONTX) reported Q1 EPS of ($1.29), $0.26 worse than the analyst estimate of ($1.03). Revenue for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE